Introduction
Gluten sensitive enteropathy is the hallmark of coeliac disease but is also seen in dermatitis herpetiformis. Diagnosis is important because untreated cases are at increased risk of gut malignancy,' often gastrointestinal T cell lymphomas. Gluten sensitive enteropathy is of interest because of the strong association with connective tissue autoantibodies, including the Rl-anti-reticulin antibody (R1-ARA),2 antiendomysial antibody (AEA)3 and anti-jejunal antibody (AJA)' in the chronological order in which they were reported (1971, 1984 and 1986, respectively) . The inter-relation between these autoantibodies has caused confusion.
The available evidence from absorption studies5 suggests that AEA and AJA are one and the same, simply giving different appearances when tested on different tissue substrates, such as monkey oesophagus and human foetal jejunum, respectively. Ultrastructural studies add further support. 6 As to whether Rl-ARA and AEA (and therefore AJA) are the same, they certainly show many common characteristics, but the common finding of R1-ARA negative, AEA positive coeliac disease cases is not entirely explained. Absorption studies by Hallstrom were not conclusive. 7 Ferreira et ar felt that "AEA was similar but not identical to R1-ARA". The author's belief is that they are the same and that the rat tissue used to detect RI-ARA/AEA is simply a less sensitive substrate than monkey oesophagus. Recently, there has been interest in the use of human umbilical cord as an alternative to monkey oesophagus for detecting these enteropathy associated connective tissue autoantibodies (see discussion under future trends).9 These autoantibodies are unique in that they are predictably invoked in susceptible patients (coeliac disease) by an environmental agent, namely gluten, disappearing within several months of a strict gluten-free diet4l '°and reappearing after gluten challenge. However, in contrast to anti-wheat protein antibodies (including anti-gliadin), and other simple food antibodies, the Rl-ARA is not seen in cases of enteropathy due to some other cause (for example, cow's milk enteropathy, Giardia infection).'0 Hence, these connective tissue autoantibodies are not generated nonspecifically following any form of small bowel damage, but instead arise by unknown mechanisms only during the development of gluten sensitive enteropathy. But, the fact that gluten sensitive enteropathy has been reported in a patient with hypogammaglobulinaemia suggests that these autoantibodies are not crucial to its pathogenesis." They are, none the less, very useful diagnostic tools by virtue of their high specificity for untreated gluten sensitive enteropathy ( 
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Serological diagnosis ofgluten sensitive enteropathy 96  21  28  28  19  GI controls  53  31  41  68  27  IgA RI-ARA  Sensitivity  ND  91  65  ND  63  Specificity   ND  99  100  ND  100  PPV  ND  91  100  ND  100  NPV  ND  99  77  ND  79  IgA AEA  Sensitivity  84  100  97  89  95  Specificity  100  99  98  100 There is no doubt that modern serology has become very reliable as a means of helping select cases of possible coeliac disease for confirmatory biopsy. But serology can be misleading and there are good reasons for retaining small bowel biopsy as the diagnostic "gold standard"."4 The classic pitfall with the IgA based autoantibody tests is false negative results in IgA deficient individuals (although, in practice, this rarely causes diagnostic difficulties in routine serological screening). Also, biopsy of seropositive patients has permitted the recognition of unusual clinical subgroups, including those with latent coeliac disease,5 16 defined as seropositivity in the face of a normal small bowel biopsy specimen but predictive of later development of enteropathy on follow up (although several years may elapse before enteropathy develops).
Finally, it should be noted that occasionally small bowel biopsy findings may be misleading '7 and that "all that flattens is not sprue". The sensible approach is to combine serology and endoscopic biopsy to ensure the most reliable diagnosis.
ANTI-GLIADIN ANTIBODY (AGA) ELISA TEST
The most popular approach is to use a solid phase ELISA assay. Crude gliadin is commercially available (Sigma, Poole, Dorset, UK). Most commercial and home made preparations will be contaminated with glutenins and other non-gliadin wheat proteins which can only be removed after complex purification steps. Fortunately, this is not necessary. There is no convincing evidence that highly purified wheat preparations such as pure alpha gliadin improves disease specificity of AGA testing. '8 In the context of using AGA tests as an inexpensive initial screen, use of crude antigen preparations is probably desirable and is certainly effective (all AGA results quoted in table 1 used crude gliadin as antigen).
ELISA METHOD
Gliadin is notoriously difficult to dissolve in saline and water. For this reason, the author uses gliadin dissolved in 70% ethanol/distilled water (final concentration of 50 jg/ml) to coat Dynatech Microelisa (Billingshurst, UK) plates at 4°C overnight as described originally in 198110; 100 tl volumes are used to coat plates and in subsequent steps. The author recommends that every third row is coated with 70% ethanol/distilled water lacking gliadin to serve as a non-specific "background binding" control. Serum samples are tested in duplicate. Coated plates are washed with phos-' phate buffered saline (PBS) (Clin-Tech, Clacton on sea, UK) with the addition of Tween 20 (BDH, Poole, UK.) to 0.05% by volume. Coated plates can now be drained and stored in airtight plastic bags at -20°C for six months. All dilutions and washes from this point on are in PBS-Tween 20 at room temperature. Serum diluted 1 in 100 is incubated for two hours before washing (three times on an automatic ELISA plate washer). Isotype specific (IgA and IgG but no gain using IgM) enzyme conjugated anti-human immunoglobulin reagents at appropriate dilutions (depends on reagent source; determine by checkerboard titration) are incubated for two hours. We use horse radish peroxidase conjugated reagents from Dako (High Wycombe, UK) for which the working dilution is of the order 1 in 10 000. After washing, the substrate (below) is prepared fresh in a light shielded bottle and after a stopclock timed five minute incubation, the reaction is stopped with 25 Figure 6 Silver impregnation of oesophagus. The epidermis (top) is unstained. The pattern seen in the muscle bundles of the lamina propria is strikingly similar to the lacework pattern seen by immunofluorescence using Rl-ARA (see fig 3) .
RI -ANTI-RETICULIN ANTIBODY
First described by Seah et al' in 1971 this relatively ancient test remains, in the author's view, useful for the reasons discussed below under "clinical utility". This antibody is detected on frozen sections cut from a tissue block composed of rat liver, kidney, and stomach (5,m thick)-that is, the same sort of substrate that is used widely for general autoantibody screening. When first observed2 a striking similarity between the tissue reactivity of the new autoantibody and the tissue distribution of "reticulin" shown by histological silver impregnation (figs 5 and 6) methods (Gomori) was noted. Hence, they were called anti-reticulin antibodies. Commercial slides with sections of frozen composite rat tissues (The Binding Site) can be used. Serum samples are screened at a dilution of 1 in 10 in PBS by the same basic immunofluorescence method described above for IgA AEA. The only difference is the substrate and the pattern of immunofluorescence seen.
The key to recognition of Rl-ARA is the observation on liver of peri-vascular staining with long fibrillar extensions into the surrounding liver parenchyma (fig 7) . The appearance is rather like a cross section through the base of a tree showing roots extending outwards. Elsewhere in the liver parenchyma, isolated hair-like fibrils are seen. These features on rat liver are the most reliable features of true Rl-ARA. Many alternative patterns of connective tissue-like staining may be seen on liver but most often these reactivities are due to heterophile antibodies, which are usually IgG and react around liver sinusoids. A positive Serological diagnosis ofgluten sensitive enteropathy result can only be recorded with confidence when the full RI-ARA pattern is seen on kidney and stomach as well as liver. On kidney, fibrillar outlining around all the kidney tubules and glomeruli is seen (fig 8) . (Note similarity to silver impregnation pattern shown in fig 5. ) On stomach, endomysial-like lacework in the subglandular muscle bundles below the muscularis mucosae, and fibrillar staining in between the gastric glands is seen (fig 9) . For practical purposes, when RI-like staining is seen on some but not all three tissues, it is advisable to record a negative result for Rl-ARA but retest the serum for AGA and AEA.
CLINICAL UTILITY OF RI -ARA As seen in table 1, Rl-ARA are highly specific for gluten sensitive enteropathy. However, this seems to be so only in experienced hands. Difficulty in recognition stems in part from the fact that there are at least five anti-reticulin staining patterns.22 Only the type 1 (RI-ARA) is associated with coeliac disease. The AEA test is easier to interpret and more sensitive for coeliac disease without loss of disease specificity. The author has never seen an IgA Ri-ARA positive that does not also show IgA AEA positivity, though the converse is not true, supporting the notion that both antibodies are the same but monkey oesophagus a more sensitive substrate. The Figure 1 1 Negative result on umbilical cord. Note smooth muscle reactivity is often seen with non-coeliac serum samples. 
